Skip to Main Content

Jill Gaidos, MD

Gastroenterology
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine

Biography

Jill Gaidos, MD, specializes in treating patients with inflammatory bowel disease (IBD), an umbrella term describing two conditions that cause chronic inflammation within the digestive system: ulcerative colitis and Crohn’s disease.

Dr. Gaidos says she was drawn to IBD because of its variety. “I like how sometimes I get to perform a procedure and see a patient only once; but, I also get to care for others over the span of many years,” she says. “You have to think about the entire patient—it’s a mix of acute and chronic cases.”

The exact causes of ulcerative colitis and Crohn’s disease are unknown, but certain factors make people more likely to develop IBD: an overactive immune system, inflammation due to “different” gut flora, and family history.

Regardless of their cause, both ulcerative colitis and Crohn’s disease share symptoms—diarrhea and abdominal discomfort, and both occur in alternating periods of flare-up (with symptoms) and remission (without symptoms).

Medication can be helpful in treating and preventing IBD flare-ups. Some people with ulcerative colitis may need surgery (to remove the colon and rectum) after living with the condition for a number of years. Similarly, surgery may also be needed to treat complications from Crohn’s disease.

Dr. Gaidos enjoys helping patients better understand their IBD and the medications that can be used to help treat their colitis or Crohn’s disease. “My goal is to get the patient to return to enjoying life again,” she says. “It’s rewarding when a patient tells me they had no idea how bad they had been feeling until they started to feel better. 

As the director of clinical research for the Yale Inflammatory Bowel Disease Program, Dr. Gaidos helps patients understand the treatment options available, as not all IBD medications work for all IBD patients. “We are learning more about what causes ulcerative colitis and Crohn’s disease,” she says. “Hopefully, one day we will be able to better predict which patients we can put on a particular drug that will work for them.”

Titles

  • Associate Professor of Medicine
  • Director of Clinical Research, Yale Inflammatory Bowel Disease Program
  • Vice Chief of Clinical Research, Digestive Diseases

Education & Training

  • Fellow
    University of Florida (2011)
  • Resident
    Virginia Commonwealth University (2008)
  • Internship
    Virginia Commonwealth University (2006)
  • MD
    Virginia Commonwealth University, Medicine (2005)

Additional Information

Biography

Jill Gaidos, MD, specializes in treating patients with inflammatory bowel disease (IBD), an umbrella term describing two conditions that cause chronic inflammation within the digestive system: ulcerative colitis and Crohn’s disease.

Dr. Gaidos says she was drawn to IBD because of its variety. “I like how sometimes I get to perform a procedure and see a patient only once; but, I also get to care for others over the span of many years,” she says. “You have to think about the entire patient—it’s a mix of acute and chronic cases.”

The exact causes of ulcerative colitis and Crohn’s disease are unknown, but certain factors make people more likely to develop IBD: an overactive immune system, inflammation due to “different” gut flora, and family history.

Regardless of their cause, both ulcerative colitis and Crohn’s disease share symptoms—diarrhea and abdominal discomfort, and both occur in alternating periods of flare-up (with symptoms) and remission (without symptoms).

Medication can be helpful in treating and preventing IBD flare-ups. Some people with ulcerative colitis may need surgery (to remove the colon and rectum) after living with the condition for a number of years. Similarly, surgery may also be needed to treat complications from Crohn’s disease.

Dr. Gaidos enjoys helping patients better understand their IBD and the medications that can be used to help treat their colitis or Crohn’s disease. “My goal is to get the patient to return to enjoying life again,” she says. “It’s rewarding when a patient tells me they had no idea how bad they had been feeling until they started to feel better. 

As the director of clinical research for the Yale Inflammatory Bowel Disease Program, Dr. Gaidos helps patients understand the treatment options available, as not all IBD medications work for all IBD patients. “We are learning more about what causes ulcerative colitis and Crohn’s disease,” she says. “Hopefully, one day we will be able to better predict which patients we can put on a particular drug that will work for them.”

Titles

  • Associate Professor of Medicine
  • Director of Clinical Research, Yale Inflammatory Bowel Disease Program
  • Vice Chief of Clinical Research, Digestive Diseases

Education & Training

  • Fellow
    University of Florida (2011)
  • Resident
    Virginia Commonwealth University (2008)
  • Internship
    Virginia Commonwealth University (2006)
  • MD
    Virginia Commonwealth University, Medicine (2005)

Additional Information